Vasa’s VS-041 shows positive Phase Ic results in HFpEF trial
Vasa Therapeutics has reported positive topline findings demonstrating clinical proof of concept for its lead therapy, VS-041, in a Phase…
Vasa Therapeutics has reported positive topline findings demonstrating clinical proof of concept for its lead therapy, VS-041, in a Phase…
The UK National Health Service (NHS) Supply Chain has awarded £184m ($243.7m) tender to Cambridge Heartwear to supply its HeartSense…
US-based St. Luke's University Health Network (SLUHN), a non-profit network with 15 campuses and more than 300 outpatient sites, has…
Intermountain Health Heart and Vascular – Delta Cardiology is set to significantly improve access to specialised medical care for the…
The University of Ottawa Heart Institute (UOHI) has partnered with TELUS and its recently acquired subsidiary Badal, which specialises in…
Canberra Hospital in Garran, Australia, is set to enhance its cardiology services with the opening of a new critical services…
Canadian health technology company WELL Health Technologies has introduced an AI-powered 'co-pilot' designed to help cardiologists identify patients at increased risk…
US non-profit multi-speciality academic medical centre Cleveland Clinic and Vinmec Health System have announced an expansion of the Cleveland Clinic…
Maine Medical Center (MMC) in Maine, US is set to enhance its patient care capabilities with the opening of the…
US-based physician-owned healthcare group CLS Health has strengthened its local foothold through a merger with Cardiac Rhythm Center, a specialist…